ACET (Adicet Bio) Forward P/E Multiple
The forward P/E multiple visualizes the valuation dynamics of Adicet Bio (ACET), which develops universal lymphoma treatments based on donor blood. The value 0.00 determines the latest valuation metric, accounting for the potential of intellectual leadership in the gamma-delta T-cell sector. High management expertise and a rigorous approach to research provide robust support for this technological platform.
Analytical breakdowns for Adicet Bio
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
ACET - Company Profit|Projected Future Earnings Adicet Bio|ACET - Business Payback Period|Forward P/E Multiple Adicet Bio|ACET - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Adicet Bio Inc.|ACET - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Adicet Bio|ACET - Earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months adicetbio.com|ACET - Earnings per share increase in current year|Earnings growth forecast for next year Adicet Bio
Summary company analytics:Adicet Bio, Inc.
Forward P/E compares current market capitalization with expected earnings, reflecting market expectations for future business efficiency. The value of 0.00 demonstrates the extent to which investors are willing to pay a premium for the potential of Adicet Bio (ACET) allogeneic T-cell therapies in the fight against oncology, allowing the company's forward P/E multiple to differentiate speculative growth from the fundamental strengthening of asset value.
Competitors of Adicet Bio (ACET)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|ABCL - Forward P/E Multiple|TRML: Forward P/E Multiple|Price to Future Earnings Ratio PGEN|PHAR (Pharming Group) - Forward P/E Multiple|Nektar Therapeutics Inc (NKTR) - Market Cap to Projected Earnings|Forward P/E Multiple UPB|Projected Price to Earnings Zenas Corp ZBIO|Forward P/E Multiple IMNM (Immunome, Inc.)|gossamerbio.com (GOSS) - Projected Price to Earnings Ratio|KALV: Projected Price to Earnings|Septerna, Inc. - Market Cap to Future Earnings Ratio|PVLA (Pieris Pharmaceuticals Inc) - Projected Price to Earnings|Savara Pharma - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|Market Cap to Projected Earnings enGene Holdings Inc|Future Price to Earnings RAPT Therapeutics, Inc. RAPT|Aerovate Therapeutics, Inc. (JBIO) - Projected Price to Earnings Ratio|Aclaris Therapeutics - Forward P/E Multiple|KYTX - Forward P/E Multiple|TLSA: Forward P/E Multiple|Projected Price to Earnings Cabaletta Bio Inc.|VTYX (Ventyx Bio) - Forward P/E Multiple|Projected Price to Earnings Ratio Theratechnologies, Inc THTX|Projected Price to Earnings AVTX (Avalo Therapeutics, Inc)|Market Cap to Future Earnings Ratio ELDN|Future Price to Earnings Agenus Inc. AGEN|CLYM (Climb Bio Inc.) - Price to Expected Earnings Ratio|Zura Bio Limited - Forward P/E Multiple|Future Price to Earnings Multiple ATYR (aTyr Pharmaceuticals)|ADAG: Forward P/E Multiple|Ikena Oncology (IMA) - Forward P/E Multiple|Future Price to Earnings Shattuck Labs Inc|EQ: Future Price to Earnings Multiple|Future Price to Earnings Connect Biopharma (CNTB)|Projected Price to Earnings immunic-therapeutics.com IMUX|Forward P/E Multiple ATRA (Atara Bio)|Forward P/E Multiple InflaRx NV IFRX|XFOR: Projected Price to Earnings|Future Price to Earnings Multiple CELU (Celularity Inc.)|INMB: Forward P/E Multiple|BRNS - Market Cap to Projected Earnings|Future Price to Earnings Kezar Life Sciences|Projected Price to Earnings sabbiotherapeutics.com (SABS)|Future Price to Earnings Akari Therapeutics Plc (AKTX)|Projected Price to Earnings enlivex.com ENLV|Q32 Bio - Projected Price to Earnings|Forward P/E Multiple GeoVax Corp GOVX|EDSA - Future Price to Earnings|IBIO (ibioinc.com) - Price to Future Earnings Ratio|CARM: Forward P/E Multiple|Projected Price to Earnings Ratio XTL Biopharmaceuticals Ltd (XTLB)|BOLT (Bolt Biotherapeutics Inc.) - Forward P/E Multiple|Forward P/E Multiple HCW Biologics Inc|Forward P/E Multiple APVO|AIM ImmunoTech, Inc. - Price to Future Earnings Ratio|Forward P/E Multiple ADTX (Aditxt, Inc.)|Market Cap to Projected Earnings GRI Bio Inc (GRI)|XORTX - Forward P/E Multiple|Vyome Therapeutics (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Projected Price to Earnings Ratio indaptusrx.com (INDP)|Projected Price to Earnings SCNI|CALI (CalciMedica Corp) - Market Cap to Future Earnings Ratio|Projected Price to Earnings AFMD (Affimed)|ALLK (allakos.com) - Future Price to Earnings Multiple|Forward P/E Multiple HOOK (HOOKIPA Pharma)|IGM Biosciences Inc. - Future Price to Earnings|iTeos Therapeutics, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings Ocean Biomedical Inc OCEA|TC BioPharm (Holdings) PLC (TCBP) - Future Price to Earnings|Projected Price to Earnings Ratio Third Harmonic Bio Inc (THRD)
